COVID-19: A Review of Emerging Preventative Vaccines and Treatment Strategies
- PMID: 32577324
- PMCID: PMC7305574
- DOI: 10.7759/cureus.8206
COVID-19: A Review of Emerging Preventative Vaccines and Treatment Strategies
Abstract
COVID-19, which was first detected in the Hubei province of China, has become a global phenomenon. The effects and devastation on both health and economy have been global. At present, there is a substantial amount of research being done to discover suitable treatment modalities. Efforts have been made on the development of potential efficacious vaccines. The development of a vaccine can be complex, expensive as well as time-consuming. Currently, various ongoing clinical trials are in progress that are investigating either pharmacologic therapies or vaccines against this virus. We, in this brief review have tried to address the process and current development efforts of vaccine in progress.
Keywords: clinical trials; coronovirus; covid-19; mrna-based vaccine; sars-cov-2; vaccine development.
Copyright © 2020, Khan et al.
Conflict of interest statement
The authors have declared that no competing interests exist.
Similar articles
-
Frontiers in the COVID-19 vaccines development.Exp Hematol Oncol. 2020 Sep 3;9:24. doi: 10.1186/s40164-020-00180-4. eCollection 2020. Exp Hematol Oncol. 2020. PMID: 32901214 Free PMC article.
-
Preventive and treatment strategies of COVID-19: From community to clinical trials.J Family Med Prim Care. 2020 May 31;9(5):2149-2157. doi: 10.4103/jfmpc.jfmpc_728_20. eCollection 2020 May. J Family Med Prim Care. 2020. PMID: 32754463 Free PMC article.
-
[The development of a vaccine - a highly regulated process].Actual Pharm. 2021 May;60(606):45-48. doi: 10.1016/j.actpha.2021.03.019. Epub 2021 May 6. Actual Pharm. 2021. PMID: 33972812 Free PMC article. Review. French.
-
A brief outlook on the current emerging trends of COVID 19 vaccines.J Oral Maxillofac Pathol. 2020 May-Aug;24(2):206-211. doi: 10.4103/jomfp.JOMFP_334_20. Epub 2020 Sep 9. J Oral Maxillofac Pathol. 2020. PMID: 33456225 Free PMC article. No abstract available.
-
Editorial: COVID-19 - The Long Road to Recovery.J Nutr Health Aging. 2020;24(9):917-919. doi: 10.1007/s12603-020-1473-6. J Nutr Health Aging. 2020. PMID: 33155615 Free PMC article. No abstract available.
Cited by
-
Towards the development of an epitope-focused vaccine for SARS-CoV-2.Vaccine. 2022 Oct 26;40(45):6489-6498. doi: 10.1016/j.vaccine.2022.09.059. Epub 2022 Sep 27. Vaccine. 2022. PMID: 36195474 Free PMC article.
-
An overview of current drugs and prophylactic vaccines for coronavirus disease 2019 (COVID-19).Cell Mol Biol Lett. 2022 May 13;27(1):38. doi: 10.1186/s11658-022-00339-3. Cell Mol Biol Lett. 2022. PMID: 35562685 Free PMC article. Review.
-
Synthetic modified messenger RNA for therapeutic applications.Acta Biomater. 2021 Sep 1;131:1-15. doi: 10.1016/j.actbio.2021.06.020. Epub 2021 Jun 13. Acta Biomater. 2021. PMID: 34133982 Free PMC article. Review.
-
Perceived Effectiveness, Safety, and Attitudes Toward the Use of Nucleic Tests of SARS-CoV-2 Among Clinicians and General Public in China.Front Public Health. 2020 Dec 17;8:599862. doi: 10.3389/fpubh.2020.599862. eCollection 2020. Front Public Health. 2020. PMID: 33392138 Free PMC article.
References
-
- Cascella M, Rajnik M, Cuomo A, Dulebohn SC, Di Napoli R. StatPearls Publishing LLC; 2020. Features, Evaluation and Treatment Coronavirus (COVID-19) - PubMed
-
- Brazilian chloroquine study halted after high dose proved lethal for some patients. [May;2020 ];https://www.theguardian.com/world/2020/apr/24/chloroquine-study-coronavi... 2020
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous